{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T18:03:34Z","timestamp":1776708214782,"version":"3.51.2"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1245\/s10434-025-17400-y","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T14:00:49Z","timestamp":1747144849000},"page":"7372-7381","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical Relevance of High-Grade Pancreatic Intraepithelial Neoplasia at the Pancreatic Transection Margin in Patients with Pancreatic Ductal Adenocarcinoma"],"prefix":"10.1245","volume":"32","author":[{"given":"Kei","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kota","family":"Sahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaro","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Yabushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Homma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Kumamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryusei","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itaru","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"17400_CR1","doi-asserted-by":"crossref","unstructured":"Schawkat K, Manning MA, Glickman JN, Mortel\u00e9 KJ. pancreatic ductal adenocarcinoma and its variants: pearls and perils. Radiographics. 2020:e190184.","DOI":"10.1148\/rg.2020190184"},{"key":"17400_CR2","doi-asserted-by":"publisher","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. Jan\u2013Feb 2024;74(1):12-49. https:\/\/doi.org\/10.3322\/caac.21820","DOI":"10.3322\/caac.21820"},{"issue":"9","key":"17400_CR3","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jama.2021.13027","volume":"326","author":"W Park","year":"2021","unstructured":"Park W, Chawla A, O\u2019Reilly EM. Pancreatic cancer: a review. JAMA. 2021;326(9):851\u201362. https:\/\/doi.org\/10.1001\/jama.2021.13027.","journal-title":"JAMA."},{"issue":"9414","key":"17400_CR4","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/s0140-6736(04)15841-8","volume":"363","author":"D Li","year":"2004","unstructured":"Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet. 2004;363(9414):1049\u201357. https:\/\/doi.org\/10.1016\/s0140-6736(04)15841-8.","journal-title":"Lancet."},{"issue":"3","key":"17400_CR5","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.surg.2020.06.042","volume":"169","author":"H Kolbeinsson","year":"2021","unstructured":"Kolbeinsson H, Hoppe A, Bayat A, et al. Recurrence patterns and postrecurrence survival after curative intent resection for pancreatic ductal adenocarcinoma. Surgery. 2021;169(3):649\u201354. https:\/\/doi.org\/10.1016\/j.surg.2020.06.042.","journal-title":"Surgery."},{"issue":"5","key":"17400_CR6","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/sla.0000000000002234","volume":"267","author":"VP Groot","year":"2018","unstructured":"Groot VP, Rezaee N, Wu W, et al. Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma. Ann Surg. 2018;267(5):936\u201345. https:\/\/doi.org\/10.1097\/sla.0000000000002234.","journal-title":"Ann Surg."},{"key":"17400_CR7","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1245\/s10434-018-6558-7","volume":"25","author":"VP Groot","year":"2018","unstructured":"Groot VP, Gemenetzis G, Blair AB, et al. Implications of the pattern of disease recurrence on survival following pancreatectomy for pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2018;25:2475\u201383.","journal-title":"Ann Surg Oncol."},{"key":"17400_CR8","doi-asserted-by":"crossref","unstructured":"Kanno A, Masamune A, Hanada K, Kikuyama M, Kitano M. Advances in early detection of pancreatic cancer. Diagnostics. 2019;9","DOI":"10.20944\/preprints201901.0133.v1"},{"key":"17400_CR9","doi-asserted-by":"publisher","first-page":"1049136","DOI":"10.3389\/fmed.2022.1049136","volume":"9","author":"J Li","year":"2022","unstructured":"Li J, Li Y, Chen C, Guo J, Qiao M, Lyu J. Recent estimates and predictions of 5-year survival rate in patients with pancreatic cancer: a model-based period analysis. Front Med (Lausanne). 2022;9:1049136. https:\/\/doi.org\/10.3389\/fmed.2022.1049136.","journal-title":"Front Med (Lausanne)."},{"key":"17400_CR10","doi-asserted-by":"publisher","DOI":"10.15761\/IMM.1000310","author":"P Korhan","year":"2017","unstructured":"Korhan P, Verkerk R, Critchley WR. Scientific rationale for integrative and personalised strategies for pancreatic ductal adenocarcinoma management. Integr Mol Med. 2017. https:\/\/doi.org\/10.15761\/IMM.1000310.","journal-title":"Integr Mol Med"},{"key":"17400_CR11","unstructured":"National Cancer Institute. (2024). SEER cancer statistics review, 1975\u20132020. https:\/\/seer.cancer.gov\/."},{"issue":"3","key":"17400_CR12","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1245\/s10434-021-11168-7","volume":"29","author":"MM Shah","year":"2022","unstructured":"Shah MM, Datta J, Merchant NB, Kooby DA. Landmark series: importance of pancreatic resection margins. Ann Surg Oncol. 2022;29(3):1542\u201350. https:\/\/doi.org\/10.1245\/s10434-021-11168-7.","journal-title":"Ann Surg Oncol."},{"issue":"8","key":"17400_CR13","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/jamasurg.2015.0668","volume":"150","author":"A Paniccia","year":"2015","unstructured":"Paniccia A, Hosokawa P, Henderson W, et al. Characteristics of 10-year survivors of pancreatic ductal adenocarcinoma. JAMA Surg. 2015;150(8):701\u201310. https:\/\/doi.org\/10.1001\/jamasurg.2015.0668.","journal-title":"JAMA Surg."},{"key":"17400_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000006539","author":"AA Javed","year":"2024","unstructured":"Javed AA, Rompen IF, van Goor I, et al. Poor prognostic factors in long-term survivors of resected pancreatic ductal adenocarcinoma: an international multicenter cohort study. Ann Surg. 2024. https:\/\/doi.org\/10.1097\/sla.0000000000006539.","journal-title":"Ann Surg"},{"key":"17400_CR15","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1097\/SLA.0000000000002345","volume":"268","author":"IE Demir","year":"2017","unstructured":"Demir IE, J\u00e4ger C, Schlitter AM, et al. R0 versus R1 resection matters after pancreaticoduodenectomy, and less after distal or total pancreatectomy for pancreatic cancer. Ann Surg. 2017;268:1058\u201368.","journal-title":"Ann Surg."},{"issue":"5","key":"17400_CR16","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/jhbp.1272","volume":"30","author":"J Kwon","year":"2023","unstructured":"Kwon J, Lee SR, Park SY, et al. Effect of resection margin status on recurrence pattern and survival in distal pancreatectomy for left-sided pancreatic ductal adenocarcinoma. J Hepatobiliary Pancreat Sci. 2023;30(5):633\u201343. https:\/\/doi.org\/10.1002\/jhbp.1272.","journal-title":"J Hepatobiliary Pancreat Sci."},{"issue":"5","key":"17400_CR17","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/00000478-200105000-00003","volume":"25","author":"RH Hruban","year":"2001","unstructured":"Hruban RH, Volkan Adsay N, Albores-Saavedra J, Compton C, Garrett ES, Goodman SN, Kern SE, Klimstra DS, Kl\u00f6ppel G, Longnecker DS, Jutta L\u00fcttges G, Offerhaus JA. Pancreatic intraepithelial neoplasia a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol. 2001;25(5):579\u201386.","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"17400_CR18","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1097\/pas.0000000000000533","volume":"39","author":"O Basturk","year":"2015","unstructured":"Basturk O, Hong SM, Wood LD, et al. A revised classification system and recommendations from the Baltimore consensus meeting for neoplastic precursor lesions in the pancreas. Am J Surg Pathol. 2015;39(12):1730\u201341. https:\/\/doi.org\/10.1097\/pas.0000000000000533.","journal-title":"Am J Surg Pathol."},{"issue":"2","key":"17400_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/01.pap.0000155055.14238.25","volume":"12","author":"A Maitra","year":"2005","unstructured":"Maitra A, Fukushima N, Takaori K, Hruban RH. Precursors to invasive pancreatic cancer. Adv Anat Pathol. 2005;12(2):81\u201391. https:\/\/doi.org\/10.1097\/01.pap.0000155055.14238.25.","journal-title":"Adv Anat Pathol."},{"issue":"4","key":"17400_CR20","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1053\/j.gastro.2011.12.042","volume":"142","author":"M Kanda","year":"2012","unstructured":"Kanda M, Matthaei H, Wu J, et al. Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia. Gastroenterology. 2012;142(4):730-733.e9. https:\/\/doi.org\/10.1053\/j.gastro.2011.12.042.","journal-title":"Gastroenterology."},{"issue":"12","key":"17400_CR21","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1245\/s10434-011-1745-9","volume":"18","author":"H Matthaei","year":"2011","unstructured":"Matthaei H, Hong SM, Mayo SC, et al. Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancer. Ann Surg Oncol. 2011;18(12):3493\u20139. https:\/\/doi.org\/10.1245\/s10434-011-1745-9.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"17400_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12957-020-01900-0","volume":"18","author":"T Jamiyan","year":"2020","unstructured":"Jamiyan T, Shiraki T, Kurata Y, Ichinose M, Kubota K, Imai Y. Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma. World J Surg Oncol. 2020;18(1):137. https:\/\/doi.org\/10.1186\/s12957-020-01900-0.","journal-title":"World J Surg Oncol."},{"key":"17400_CR23","unstructured":"Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO Classification of Tumours of the Digestive System. 2010."},{"key":"17400_CR24","unstructured":"WHO Classification of Tumours Editorial Board. ed. Digestive System Tumours. WHO Classification of Tumours. 5th ed, Lyon: IARC Press, 2019."},{"key":"17400_CR25","unstructured":"Edge SB, American Joint Committee on Cancer ACS. AJCC Cancer Staging Handbook: from the AJCC Cancer Staging Manual. vol 19. Springer; 2010."},{"key":"17400_CR26","doi-asserted-by":"crossref","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours. John Wiley & Sons; 2017.","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"issue":"4","key":"17400_CR27","doi-asserted-by":"publisher","first-page":"439","DOI":"10.6004\/jnccn.2021.0017","volume":"19","author":"MA Tempero","year":"2021","unstructured":"Tempero MA, Malafa MP, Al-Hawary M, et al. Pancreatic adenocarcinoma, Version, 2.2021 NCCN Clinical Practice Guidelines in oncology. J Natl Compr Canc Netw. 2021;19(4):439\u201357. https:\/\/doi.org\/10.6004\/jnccn.2021.0017.","journal-title":"J Natl Compr Canc Netw."},{"issue":"3","key":"17400_CR28","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/mpa.0000000000001513","volume":"49","author":"T Okusaka","year":"2020","unstructured":"Okusaka T, Nakamura M, Yoshida M, et al. Clinical practice guidelines for pancreatic cancer 2019 from the Japan Pancreas Society: a synopsis. Pancreas. 2020;49(3):326\u201335. https:\/\/doi.org\/10.1097\/mpa.0000000000001513.","journal-title":"Pancreas."},{"issue":"5","key":"17400_CR29","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/mpa.0000000000000816","volume":"46","author":"K Yamaguchi","year":"2017","unstructured":"Yamaguchi K, Okusaka T, Shimizu K, et al. Clinical practice guidelines for pancreatic cancer 2016 from the Japan Pancreas Society: a synopsis. Pancreas May\/Jun. 2017;46(5):595\u2013604. https:\/\/doi.org\/10.1097\/mpa.0000000000000816.","journal-title":"Pancreas. May\/Jun"},{"issue":"10","key":"17400_CR30","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1093\/jjco\/hyu127","volume":"44","author":"K Yamaguchi","year":"2014","unstructured":"Yamaguchi K, Okusaka T, Shimizu K, et al. EBM-based clinical guidelines for pancreatic cancer (2013) issued by the Japan Pancreas Society: a synopsis. Jpn J Clin Oncol. 2014;44(10):883\u20138. https:\/\/doi.org\/10.1093\/jjco\/hyu127.","journal-title":"Jpn J Clin Oncol."},{"issue":"7","key":"17400_CR31","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1093\/jjco\/hyr077","volume":"41","author":"K Yamaguchi","year":"2011","unstructured":"Yamaguchi K, Tanaka M. EBM-based clinical guidelines for pancreatic cancer 2009 from the Japan Pancreas Society: a synopsis. Jpn J Clin Oncol. 2011;41(7):836\u201340. https:\/\/doi.org\/10.1093\/jjco\/hyr077.","journal-title":"Jpn J Clin Oncol."},{"issue":"10041","key":"17400_CR32","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/s0140-6736(16)30583-9","volume":"388","author":"K Uesaka","year":"2016","unstructured":"Uesaka K, Boku N, Fukutomi A, et al. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). Lancet. 2016;388(10041):248\u201357. https:\/\/doi.org\/10.1016\/s0140-6736(16)30583-9.","journal-title":"Lancet."},{"issue":"3","key":"17400_CR33","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/jama.297.3.267","volume":"297","author":"H Oettle","year":"2007","unstructured":"Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA. 2007;297(3):267\u201377. https:\/\/doi.org\/10.1001\/jama.297.3.267.","journal-title":"JAMA."},{"issue":"8","key":"17400_CR34","first-page":"2969","volume":"6","author":"RH Hruban","year":"2000","unstructured":"Hruban RH, Goggins M, Parsons J, Kern SE. Progression model for pancreatic cancer. Clin Cancer Res. 2000;6(8):2969\u201372.","journal-title":"Clin Cancer Res."},{"issue":"6","key":"17400_CR35","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/s1535-6108(03)00309-x","volume":"4","author":"SR Hingorani","year":"2003","unstructured":"Hingorani SR, Petricoin EF, Maitra A, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell. 2003;4(6):437\u201350. https:\/\/doi.org\/10.1016\/s1535-6108(03)00309-x.","journal-title":"Cancer Cell."},{"issue":"5","key":"17400_CR36","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1053\/j.gastro.2013.07.049","volume":"145","author":"SJ Murphy","year":"2013","unstructured":"Murphy SJ, Hart SN, Lima JF, et al. Genetic alterations associated with progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumor. Gastroenterology. 2013;145(5):1098-1109.e1. https:\/\/doi.org\/10.1053\/j.gastro.2013.07.049.","journal-title":"Gastroenterology."},{"issue":"7319","key":"17400_CR37","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/nature09515","volume":"467","author":"S Yachida","year":"2010","unstructured":"Yachida S, Jones S, Bozic I, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature. 2010;467(7319):1114\u20137. https:\/\/doi.org\/10.1038\/nature09515.","journal-title":"Nature."},{"issue":"20","key":"17400_CR38","first-page":"4740","volume":"58","author":"RE Wilentz","year":"1998","unstructured":"Wilentz RE, Geradts J, Maynard R, et al. Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res. 1998;58(20):4740\u20134.","journal-title":"Cancer Res."},{"issue":"12","key":"17400_CR39","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1097\/00000478-200312000-00001","volume":"27","author":"C Rosty","year":"2003","unstructured":"Rosty C, Geradts J, Sato N, et al. p16 Inactivation in pancreatic intraepithelial neoplasias (PanINs) arising in patients with chronic pancreatitis. Am J Surg Pathol. 2003;27(12):1495\u2013501. https:\/\/doi.org\/10.1097\/00000478-200312000-00001.","journal-title":"Am J Surg Pathol."},{"issue":"5","key":"17400_CR40","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3390\/cancers13050945","volume":"13","author":"R Sagami","year":"2021","unstructured":"Sagami R, Yamao K, Nakahodo J, et al. Pre-operative imaging and pathological diagnosis of localized high-grade pancreatic intra-epithelial neoplasia without invasive carcinoma. Cancers. 2021;13(5):945.","journal-title":"Cancers."},{"issue":"2","key":"17400_CR41","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/his.13629","volume":"73","author":"M Yokode","year":"2018","unstructured":"Yokode M, Akita M, Fujikura K, et al. High-grade PanIN presenting with localised stricture of the main pancreatic duct: a clinicopathological and molecular study of 10 cases suggests a clue for the early detection of pancreatic cancer. Histopathology. 2018;73(2):247\u201358. https:\/\/doi.org\/10.1111\/his.13629.","journal-title":"Histopathology."},{"issue":"1","key":"17400_CR42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/path.4884","volume":"242","author":"W Hosoda","year":"2017","unstructured":"Hosoda W, Chianchiano P, Griffin JF, et al. Genetic analyses of isolated high-grade pancreatic intraepithelial neoplasia (HG-PanIN) reveal paucity of alterations in TP53 and SMAD4. J Pathol. 2017;242(1):16\u201323. https:\/\/doi.org\/10.1002\/path.4884.","journal-title":"J Pathol."},{"issue":"7","key":"17400_CR43","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/jhbp.361","volume":"23","author":"S Sato","year":"2016","unstructured":"Sato S, Nakamura F, Hiroshima Y, et al. Caerulein-induced pancreatitis augments the expression and phosphorylation of collapsin response mediator protein 4. J Hepatobiliary Pancreat Sci. 2016;23(7):422\u201331. https:\/\/doi.org\/10.1002\/jhbp.361.","journal-title":"J Hepatobiliary Pancreat Sci."},{"issue":"3","key":"17400_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100746","volume":"13","author":"K Yazawa","year":"2020","unstructured":"Yazawa K, Nakamura F, Masukawa D, et al. Low incidence of high-grade pancreatic intraepithelial neoplasia lesions in a Crmp4 gene-deficient mouse model of pancreatic cancer. Transl Oncol. 2020;13(3):100746. https:\/\/doi.org\/10.1016\/j.tranon.2020.100746.","journal-title":"Transl Oncol."},{"issue":"8","key":"17400_CR45","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrgastro.2011.114","volume":"8","author":"B Kong","year":"2011","unstructured":"Kong B, Michalski CW, Erkan M, Friess H, Kleeff J. From tissue turnover to the cell of origin for pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2011;8(8):467\u201372. https:\/\/doi.org\/10.1038\/nrgastro.2011.114.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"2","key":"17400_CR46","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/00000478-199802000-00003","volume":"22","author":"DJ Brat","year":"1998","unstructured":"Brat DJ, Lillemoe KD, Yeo CJ, Warfield PB, Hruban RH. Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. Am J Surg Pathol. 1998;22(2):163\u20139. https:\/\/doi.org\/10.1097\/00000478-199802000-00003.","journal-title":"Am J Surg Pathol."},{"issue":"5","key":"17400_CR47","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/s1092-9134(98)80020-8","volume":"2","author":"E Brockie","year":"1998","unstructured":"Brockie E, Anand A, Albores-Saavedra J. Progression of atypical ductal hyperplasia\/carcinoma in situ of the pancreas to invasive adenocarcinoma. Ann Diagn Pathol. 1998;2(5):286\u201392. https:\/\/doi.org\/10.1016\/s1092-9134(98)80020-8.","journal-title":"Ann Diagn Pathol."},{"issue":"2","key":"17400_CR48","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1001\/archsurg.2009.282","volume":"145","author":"J Fatima","year":"2010","unstructured":"Fatima J, Schnelldorfer T, Barton J, et al. Pancreatoduodenectomy for ductal adenocarcinoma: implications of positive margin on survival. Arch Surg. 2010;145(2):167\u201372. https:\/\/doi.org\/10.1001\/archsurg.2009.282.","journal-title":"Arch Surg."},{"issue":"6","key":"17400_CR49","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1097\/sla.0000000000002345","volume":"268","author":"IE Demir","year":"2018","unstructured":"Demir IE, J\u00e4ger C, Schlitter AM, et al. R0 versus R1 resection matters after pancreaticoduodenectomy, and less after distal or total pancreatectomy for pancreatic cancer. Ann Surg. 2018;268(6):1058\u201368. https:\/\/doi.org\/10.1097\/sla.0000000000002345.","journal-title":"Ann Surg."},{"issue":"7","key":"17400_CR50","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1097\/mpa.0000000000000161","volume":"43","author":"BG Hassid","year":"2014","unstructured":"Hassid BG, Lucas AL, Salomao M, et al. Absence of pancreatic intraepithelial neoplasia predicts poor survival after resection of pancreatic cancer. Pancreas. 2014;43(7):1073\u20137. https:\/\/doi.org\/10.1097\/mpa.0000000000000161.","journal-title":"Pancreas."},{"issue":"2","key":"17400_CR51","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/s1499-3872(16)60186-8","volume":"16","author":"JR Park","year":"2017","unstructured":"Park JR, Li F, Oza VM, et al. High-grade pancreatic intraepithelial lesions: prevalence and implications in pancreatic neoplasia. Hepatobiliary Pancreat Dis Int. 2017;16(2):202\u20138. https:\/\/doi.org\/10.1016\/s1499-3872(16)60186-8.","journal-title":"Hepatobiliary Pancreat Dis Int."},{"key":"17400_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11020287","author":"J Ikemoto","year":"2021","unstructured":"Ikemoto J, Serikawa M, Hanada K, et al. Clinical analysis of early-stage pancreatic cancer and proposal for a new diagnostic algorithm: a multicenter observational study. Diagnostics (Basel). 2021. https:\/\/doi.org\/10.3390\/diagnostics11020287.","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"17400_CR53","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.pan.2024.06.006","volume":"24","author":"R Sagami","year":"2024","unstructured":"Sagami R, Mizukami K, Nishikiori H, et al. Pancreatic juice cytology for diagnosing invasive pancreatic carcinoma\/high-grade pancreatic intraepithelial neoplasia without visible tumors on endoscopic ultrasound. Pancreatology. 2024;24(5):740\u20136. https:\/\/doi.org\/10.1016\/j.pan.2024.06.006.","journal-title":"Pancreatology."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17400-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17400-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17400-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T14:04:16Z","timestamp":1758549856000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17400-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["17400"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17400-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest. The study protocol was approved by the Ethical Advisory Committee of Yokohama City University Graduate School of Medicine and the institutional review board (B180600049\/B180600056).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}